The NUTRIENT Trial (NUTRitional Intervention among myEloproliferative Neoplasms): Feasibility Phase

PURPOSE: Chronic inflammation is integral to Myeloproliferative Neoplasm (MPN) pathogenesis. JAK inhibitors reduce cytokine levels, but not without significant side effects. Nutrition is a low-risk approach to reduce inflammation and ameliorate symptoms in MPN. We performed a randomized, parallel-ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendez Luque, Laura F., Avelar-Barragan, Julio, Nguyen, Hellen, Nguyen, Jenny, Soyfer, Eli M., Liu, Jiarui, Chen, Jane H., Mehrotra, Nitya, Kosiorek, Heidi E., Dueck, Amylou, Himstead, Alexander, Heide, Elena, Lem, Melinda, Alaoui, Kenza El, Marin, Eduard Mas, Scherber, Robyn M., Mesa, Ruben A., Whiteson, Katrine L., Odegaard, Andrew, Fleischman, Angela G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197802/
https://www.ncbi.nlm.nih.gov/pubmed/37214789
http://dx.doi.org/10.1101/2023.05.09.23289740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197802/
https://www.ncbi.nlm.nih.gov/pubmed/37214789
http://dx.doi.org/10.1101/2023.05.09.23289740

Ejemplares similares